Compare ANDG & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANDG | AORT |
|---|---|---|
| Founded | 2002 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | N/A | 1996 |
| Metric | ANDG | AORT |
|---|---|---|
| Price | $22.33 | $38.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $29.50 | ★ $48.76 |
| AVG Volume (30 Days) | 297.0K | ★ 453.0K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.21 |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | $15.11 | $13.95 |
| Revenue Next Year | $14.96 | $11.16 |
| P/E Ratio | ★ $44.38 | $170.38 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $18.12 | $21.97 |
| 52 Week High | $26.85 | $48.25 |
| Indicator | ANDG | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 53.83 | 43.44 |
| Support Level | $19.08 | $30.24 |
| Resistance Level | $22.75 | $44.29 |
| Average True Range (ATR) | 1.63 | 1.67 |
| MACD | 0.29 | -0.05 |
| Stochastic Oscillator | 99.68 | 58.32 |
Andersen Group Inc is a provider of independent tax, valuation and financial advisory services to individuals and family offices, businesses and institutional clients in the United States. It has strategically expanded its business to build an integrated platform of service offerings that enables the company to solve its clients' complex tax and financial challenges. The company's end-to-end services offerings include: Private Client Services, Business Tax Services, Alternative Investment Funds, and Valuation Services.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.